NCT06094452
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
Clinical trial condition
Neurocognitive Disorders
Explore clinical trials studying Neurocognitive Disorders. Study availability and eligibility vary by location and protocol.
7,801 public trials
1,436 recruiting studies
Neurocognitive Disorders trial results
NCT05741047
- Conditions
- Adults, Cognition Disorders, Cognitive Dysfunction, +3 more
- Locations
-
- General Hospital of Tianjin Medical University Tianjin, China
- The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine Tianjin, China
NCT05114187
- Conditions
- Alzheimer Disease, Behavior, Behavioral Symptoms, +13 more
- Locations
-
- McMaster University Hamilton, Ontario, Canada
NCT04796415
- Conditions
- Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +2 more
- Locations
-
- Kindred at Home Indianapolis, Indiana, United States
NCT05628636
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- RDC Clinical Newstead, Queensland, Australia
NCT00693121
- Conditions
- Brain Diseases, Brain Injuries, Brain Injuries, Traumatic, +15 more
- Locations
-
- Methodist Rehabilitation Center Jackson, Mississippi, United States
NCT05408780
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Quotient Sciences Miami Miami, Florida, United States
NCT03061474
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
- Locations
-
- University of California, Irvine Irvine, California, United States
- University of California, Los Angeles Los Angeles, California, United States
NCT03435705
- Conditions
- Alzheimer Disease, Alzheimer's Disease or Related Disorder, Brain Diseases, +7 more
- Locations
-
- Aapam-Ssiad Blaignan, France
- SESAME Bordeaux, France
- Castelsanté Casteljaloux, France
- SSIAD Hauts de garonne Cenon, France
Completed
A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)
NCT02754830
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Parexel Early Phase Unit at Glendale Glendale, California, United States
- PAREXEL-Phase 1 Baltimore Harbor Hospital Center Baltimore, Maryland, United States